PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:14 AM ET

Sponsor Check › Person

BL
No photo found yet (own website and image search run after this page is viewed)

Bryan Lawlis

Named as an officer, director or promoter on SEC Form D filings · CA, WA · Apr 21, 2016 → Jun 6, 2018

2deals (issuers)
$210.4Mreported sold
46investors
3Form D filings
2016–2018years on file

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:36 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Bryan Lawlis is listed as a director on 3 SEC Form D filings by 2 issuers between Apr 2016 and Dec 2019: AbSci Corp (Vancouver, WA — biotechnology — 2016–2019; $125M reported sold to 31 investors) and SUTRO BIOPHARMA INC (South San Francisco, CA — biotechnology — 2018; $85.4M reported sold to 15 investors).

What this means 2 separate companies raised money with this person listed as director, over about 3 years. Across those companies the filings report $210.4M sold in total.

Listed alongside Daniel Gold (2 shared filings), Sean McClain (2 shared filings), Zach Jonasson (2 shared filings), Armen Shanafelt (1 shared filing), Daniel Janney (1 shared filing) and 7 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Bryan. Each name links to their own page.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 2 court cases matching the name listed in Key records below.

What this means 2 records came back, including 2 court cases still open — open cases can take years and cost money. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 3 public filings for Bryan Lawlis and found 8 differences, 1 worth asking the sponsor about: Bryan Lawlis is no longer listed on the Aug 8, 2018 amendment; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Bryan Lawlis has not run yet — it is joining a line of 10,271 names; searches run around the clock at the hosts' allowed rate. Searched so far: 27 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

2 cases: 2 open

Lawlis v. West Edge, LLC open
District Court, D. Colorado · No. 1:26-cv-03589 · Filed Aug 7, 2026
Role of Lawlis: Plaintiff · Outcome: Open — no termination date on the docket (bulk snapshot 2026-09-30) Docket on CourtListener ↗
same rare surname (3 people in Form D filings, 5 federal dockets); surname only in the caption; court in CO (not a filing state)
Lawlis v. Prism Hospitality, L.P open
District Court, W.D. Texas · No. 5:25-cv-01010 · Filed Aug 15, 2025
Role of Lawlis: Plaintiff · Outcome: Open — no termination date on the docket (bulk snapshot 2026-09-30) Docket on CourtListener ↗
same rare surname (3 people in Form D filings, 5 federal dockets); surname only in the caption; court in TX (not a filing state)
What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:36 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Bryan Lawlis..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:36 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

8 differences found between the filings for Bryan Lawlis — 1 worth asking about (compared 3 filings on Oct 24, 2026)

Worth asking · Jun 6, 2018 – Aug 8, 2018

Bryan Lawlis is no longer listed on the Aug 8, 2018 amendment — SUTRO BIOPHARMA INC

Bryan Lawlis appears on the Jun 6, 2018 Form D (director) but not on the Aug 8, 2018 Form D/A for the same offering.

What this means People leave, and the issuer must list only current officers, directors and promoters. It is still worth asking why this person left and who replaced them.

Sources
Note · Jun 6, 2018 – Aug 8, 2018

Offering amount changed between filings — SUTRO BIOPHARMA INC

The Jun 6, 2018 filing says $60,000,000 offered; the Aug 8, 2018 Form D/A says $85,382,351.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Sources
Note · Dec 5, 2019 – Dec 19, 2019

No amendment in the last 12 months on an offering that may still be open — AbSci Corp (latest filing Dec 19, 2019)

The latest filing for this offering is dated Dec 19, 2019 (first sale Dec 5, 2019). It reports $10,360,013 sold of $15,000,000 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Note · Apr 6, 2016 – Apr 21, 2016

No amendment in the last 12 months on an offering that may still be open — AbSci Corp (latest filing Apr 21, 2016)

The latest filing for this offering is dated Apr 21, 2016 (first sale Apr 6, 2016). It reports $3,661,572 sold of $6,000,000 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Note · Apr 21, 2016 – Dec 19, 2019

Address moved from Portland, OR to Vancouver, WA — AbSci Corp

The people listed on the Apr 21, 2016 filing give Portland, OR; on the Dec 19, 2019 filing they give Vancouver, WA.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Sources
Note · Apr 21, 2016 – Dec 19, 2019

Bryan Lawlis is listed with 2 different address states: CA, WA

CA on 2 filings (Apr 21, 2016 to Jun 6, 2018); WA on 1 filing (Dec 19, 2019).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Sources
Note · Apr 21, 2016

Formed in 2020 per the latest filing, but activity is dated 2016 — AbSci Corp

The issuer's latest filing says it was formed in 2020. The Apr 21, 2016 filing says the first sale was Apr 6, 2016 — before that year.

What this means A company cannot sell before it exists, so one of the two dates is likely a typo on the form. Ask the sponsor for the formation document.

Sources
Note · Apr 21, 2016 – Dec 19, 2019

Reported revenue range changed between filings — AbSci Corp

"$1 - $1,000,000" (Apr 21, 2016); then "$1,000,001 - $5,000,000" (Dec 19, 2019).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

0 of 3 offerings report sales commissions; 0 report finder's fees; 2 report proceeds to related persons totalling $1,325,000. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Dec 19, 2019 D
AbSci Corp
File 021-355883
$0$0$1,000,000None no CRD number reportedEDGAR ↗
Jun 6, 2018 D
SUTRO BIOPHARMA INC
File 021-314024
$0$0$0None listed on this filingEDGAR ↗
Apr 21, 2016 D
AbSci Corp
File 021-261810
$0$0$325,000 (est.)None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 2

Every issuer that named Bryan Lawlis on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

Biotechnology

AbSci Corp

Vancouver, WA · Apr 21, 2016 → Dec 19, 2019 · 2 filings
  • Dec 19, 2019 · D · $10,360,013 sold of $15,000,000 · 17 investors · min. $10,000 · role: Director EDGAR ↗
  • Apr 21, 2016 · D · $3,661,572 sold of $6,000,000 · 12 investors · min. $10,000 · role: Director EDGAR ↗

Raised $125M from 31 investors (100% of the $15M target) as of the latest filing. Bryan is listed as director on 2 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Biotechnology

SUTRO BIOPHARMA INC

South San Francisco, CA · Jun 6, 2018
  • Jun 6, 2018 · D · $31,624,999 sold of $60,000,000 · 8 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $85.4M from 15 investors (100% of the $60M target) as of the latest filing. Bryan is listed as director.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

People around Bryan 12

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

SM
No photo found yet (own website and image search run after this page is viewed)
Person

Sean McClain

Executive Officer, Director · 2 shared filings (1 issuer)

Listed on the same filings as Bryan Lawlis. Their page shows their other deals.

ZJ
No photo found yet (own website and image search run after this page is viewed)
Person

Zach Jonasson

Director · 2 shared filings (1 issuer)

Listed on the same filings as Bryan Lawlis. Their page shows their other deals.

DG
No photo found yet (own website and image search run after this page is viewed)
Person

Daniel Gold

Director · 2 shared filings (1 issuer)

Listed on the same filings as Bryan Lawlis. Their page shows their other deals.

PB
No photo found yet (own website and image search run after this page is viewed)
Person

Phil Barish

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Bryan Lawlis. Their page shows their other deals.

GM
No photo found yet (own website and image search run after this page is viewed)
Person

Gustavo Mahler

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Bryan Lawlis. Their page shows their other deals.

SK
No photo found yet (own website and image search run after this page is viewed)
Person

Shelley Klassen

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Bryan Lawlis. Their page shows their other deals.

JL
No photo found yet (own website and image search run after this page is viewed)
Person

Joseph Lobacki

Director · 1 shared filing (1 issuer)

Listed on the same filings as Bryan Lawlis. Their page shows their other deals.

MR
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Ross

Director · 1 shared filing (1 issuer) · also on 29 other issuers

Michael Ross is on 30 issuers in total — a repeat sponsor. Their page lists every one.

DJ
No photo found yet (own website and image search run after this page is viewed)
Person

Daniel Janney

Director · 1 shared filing (1 issuer) · also on 5 other issuers

Daniel Janney is on 6 issuers in total — a repeat sponsor. Their page lists every one.

AS
No photo found yet (own website and image search run after this page is viewed)
Person

Armen Shanafelt

Director · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as Bryan Lawlis. Their page shows their other deals.

JF
No photo found yet (own website and image search run after this page is viewed)
Person

John Freund

Director · 1 shared filing (1 issuer) · also on 6 other issuers

John Freund is on 7 issuers in total — a repeat sponsor. Their page lists every one.

WN
No photo found yet (own website and image search run after this page is viewed)
Person

William Newell

Executive Officer, Director · 1 shared filing (1 issuer) · also on 4 other issuers

William Newell is on 5 issuers in total — a repeat sponsor. Their page lists every one.

The team behind the deals

Same business address

1 other issuer file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Adviser registration (Form ADV)

None of the 2 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Bryan Lawlis by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 2 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Bryan Lawlis is listed on: none on file. No website or social profile named in SUTRO BIOPHARMA INC's SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #250,615 of 374,652 in line (14 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (South San Francisco, CA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Bryan Lawlis appears on a new Form D, or when a court case or SEC action is matched to them. See plans →